Bracialeto
-
Franchise India Bureau Oct 24 2018 - 1 min readSun Pharmaceutical Industries Ltd has announced the launch of Ilumya (tildrakizumab-asmn), its plaque psoriasis treatment drug, in the United States (US) market. Ilumya in the strength of 100 mg/mL has been introduced in the US for the treatment of moderate-to-severe psoriasis. Abhay Gandhi, Sun Pharma North America CEO, said, "The availability of Ilumya is an ...
-
Abha Garyali Sep 29 2017 - 4 min readWith the price of gold touching the sky, costume jewellery is more in demand. This has led to the emergence of many brands in the fashion jewellery sector, and Bracialeto is one such brand. In an interview Viral Shah, CEO, Bracialeto shares with us the brand’s future aspirations via franchising. Abha Garyali (AG): Share with ...